Current management and use of oral immunotherapy in the United States for patients with peanut allergy

摘要

Background: Peanut allergy is a major health burden in the United States. Treatment is limited to avoidance and acute reaction management. No drug or medical product is approved for use as a peanut oral immunotherapy (POIT) agent.